NCT05288075View on ClinicalTrials.gov

Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

June 27, 2022

Study Completion Date

June 27, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

Indacaterol/glycopyrronium

"In each period, subjects receive single dose of indacaterol/glycopyrronium consisting of 2 inhaled doses via Easyhaler or 2 capsules inhaled via Ultibro Breezhaler.~In addition to study treatments, activated charcoal will be administered on each study period before and after study drug administration."

Trial Locations (1)

Unknown

CRST Helsinki Oy, Helsinki

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY